01 Who We Are Deeply integrated, Relay Therapeutics® is a clinical-stage precision medicine company that sits at the intersection of computational and experimental technologies. Relay Therapeutics' Approach Relay Therapeutics was built upon unparalleled insights into protein motion and how this dynamic behavior relates to protein function. These insights are driven by our Dynamo platform, which integrates an array of leading-edge experimental and computational approaches and enables us to effectively drug protein targets that have previously been intractable or inadequately addressed. Three important forces led to the founding of Relay Therapeutics: Genomic Data Computation Experimentation Genomic Data The genomic revolution has enabled a better understanding of the targets that drive disease, and which patients may benefit from new targeted therapies. Experimental Resolution Structural biology techniques emerged that finally allow scientists to visualize protein motion at atomic resolutions. Computational Power and Speed Technology improved to the point that molecular dynamics simulations can be run on proteins at biologically relevant timescales useful for drug discovery. 2016 Success Through Integration Our Dynamo platform integrates an array of leading-edge experimental and computational approaches that enable us to drug these targets by providing a differentiated understanding of protein structure and motion. Our Platform We are advancing a pipeline of promising therapeutic candidates, with an initial focus on precision oncology and genetic disease. Our Pipeline Who We Are Our Team Dynamo Platform Pipeline Patients Investors & Media Careers Contact Relay Therapeutics 399 Binney Street, 2nd Floor Cambridge, MA 02139 info@relaytx.com (617) 370-8837 © Relay Therapeutics 2020 Privacy Policy Terms of Use